Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 23577085)

1.

Association between P(16INK4a) promoter methylation and non-small cell lung cancer: a meta-analysis.

Gu J, Wen Y, Zhu S, Hua F, Zhao H, Xu H, You J, Sun L, Wang W, Chen J, Zhou Q.

PLoS One. 2013;8(4):e60107. doi: 10.1371/journal.pone.0060107. Epub 2013 Apr 5.

2.

[A meta-analysis of Association between MGMT gene promoter methylation and non-small cell lung cancer].

Fang N, Gu J, Wei H, You J, Zhou Q.

Zhongguo Fei Ai Za Zhi. 2014 Aug 20;17(8):601-5. doi: 10.3779/j.issn.1009-3419.2014.08.04. Chinese.

3.

A meta-analysis of the relationship between RARβ gene promoter methylation and non-small cell lung cancer.

Hua F, Fang N, Li X, Zhu S, Zhang W, Gu J.

PLoS One. 2014 May 5;9(5):e96163. doi: 10.1371/journal.pone.0096163. eCollection 2014.

4.

Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.

Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.

Int J Oncol. 2001 Aug;19(2):277-81.

PMID:
11445839
5.

Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.

Gu C, Lu J, Cui T, Lu C, Shi H, Xu W, Yuan X, Yang X, Huang Y, Lu M.

PLoS One. 2013 Sep 26;8(9):e72633. doi: 10.1371/journal.pone.0072633. eCollection 2013.

6.

Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.

Liu WJ, Tan XH, Guo BP, Ke Q, Sun J, Cen H.

Asian Pac J Cancer Prev. 2013;14(6):3719-24.

7.

Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis.

Zhang B, Zhu W, Yang P, Liu T, Jiang M, He ZN, Zhang SX, Chen WQ, Chen W.

PLoS One. 2011;6(12):e28882. doi: 10.1371/journal.pone.0028882. Epub 2011 Dec 13.

8.

Prognostic significance of p16(INK4a) hypermethylation in non-small cell lung cancer is evident by quantitative DNA methylation analysis.

Ota N, Kawakami K, Okuda T, Takehara A, Hiranuma C, Oyama K, Ota Y, Oda M, Watanabe G.

Anticancer Res. 2006 Sep-Oct;26(5B):3729-32.

9.

Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.

Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.

Oncogene. 2001 Jun 14;20(27):3528-32.

10.
11.

p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.

Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.

Clin Cancer Res. 2002 Dec;8(12):3782-7.

12.

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K.

Int J Cancer. 2003 Oct 10;106(6):913-8.

PMID:
12918069
13.

Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.

Ekim M, Caner V, Büyükpınarbaşılı N, Tepeli E, Elmas L, Bağcı G.

Genet Test Mol Biomarkers. 2011 May;15(5):357-60. doi: 10.1089/gtmb.2010.0211. Epub 2011 Feb 2.

PMID:
21288129
14.

Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.

Zhang Y, Miao Y, Yi J, Wang R, Chen L.

Clin Lung Cancer. 2010 Jul 1;11(4):264-70. doi: 10.3816/CLC.2010.n.034.

PMID:
20630829
15.

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.

An Q, Liu Y, Gao Y, Huang J, Fong X, Li L, Zhang D, Cheng S.

Cancer Lett. 2002 Dec 15;188(1-2):109-14.

PMID:
12406555
16.

The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.

Lou-Qian Z, Rong Y, Ming L, Xin Y, Feng J, Lin X.

PLoS One. 2013;8(1):e54970. doi: 10.1371/journal.pone.0054970. Epub 2013 Jan 25. Review.

17.

The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.

Wang J, Wang B, Chen X, Bi J.

Carcinogenesis. 2011 Mar;32(3):411-6. doi: 10.1093/carcin/bgq266. Epub 2010 Dec 14.

18.

p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.

Cancer Res. 2001 Apr 15;61(8):3419-24.

19.

Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.

Cancer Res. 2001 Jan 1;61(1):249-55.

20.

CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.

Bradly DP, Gattuso P, Pool M, Basu S, Liptay M, Bonomi P, Buckingham L.

Diagn Mol Pathol. 2012 Dec;21(4):207-13. doi: 10.1097/PDM.0b013e31825554b2.

PMID:
23111194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk